Last reviewed · How we verify

Thenylene (METHAPYRILENE)

FDA-approved withdrawn Small molecule Quality 23/100

At a glance

Generic nameMETHAPYRILENE
Target5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results